William Tanner

Stock Analyst

(n/a)

# 4,407

Out of 4,413 analysts

5

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PRTA Prothena Corporation	Assumes: Overweight	n/a	$21.42	-	3	Mar 4, 2019
	TXMD TherapeuticsMD	Maintains: Overweight	n/a	$1.89	-	1	Aug 14, 2018
	XNCR Xencor	Initiates: Overweight	n/a	$23.93	-	1	Nov 29, 2017

Prothena Corporation

Mar 4, 2019

Assumes: Overweight

Price Target: n/a

Current: $21.42

Upside: -

TherapeuticsMD

Aug 14, 2018

Maintains: Overweight

Price Target: n/a

Current: $1.89

Upside: -

Xencor

Nov 29, 2017

Initiates: Overweight

Price Target: n/a

Current: $23.93

Upside: -